Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Patent
1995-09-13
1997-06-24
Criares, Theodore J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Cyclopentanohydrophenanthrene ring system doai
514168, A61K 3156
Patent
active
056417667
ABSTRACT:
Alzheimer's disease and immune deficiency disorders may be effectively treated by administering a .DELTA.5-Androstene-3.beta.-ol-17-one having a C.sub.7 substituent selected from the group consisting of oxo, hydroxy and groups convertible thereto by hydrolysis by administering a therapeutic amount of a .DELTA.5-Androstene-3.beta.-ol-17-one having a C.sub.7 substituent selected from the group consisting of oxo, hydroxy and groups convertible thereto by hydrolysis.
REFERENCES:
patent: 5028631 (1991-07-01), Schwartz et al.
patent: 5206008 (1993-04-01), Loria
patent: 5227907 (1993-07-01), Loria
patent: 5292730 (1994-03-01), Lardy
patent: 5489581 (1996-02-01), Daynes et al.
patent: 5518725 (1996-05-01), Daynes et al.
patent: 5532230 (1996-07-01), Daynes et al.
patent: 5540919 (1996-07-01), Daynes et al.
Araneo et al., "Administration of Dehydroepiandrosterone to Burned Mice Preserves Normal Immunologic Competence," Arch Surg, vol. 128, pp. 318-325, Mar. 1993.
Araneo et al., "Dehydropepiandrosterone Reduces Progressive Dermal Ischemia Caused by Thermal Injury," Journal of Surgical Research, vol. 59, No. 2, pp. 250-262, Aug. 1995.
Araneo et al., "Dehydropepiandrosterone Functions as More Than an Antiglucocorticoid in Preserving Immunocompetence after Thermal Injury," Endocrinology, vol. 136, No. 2, pp. 393-401, 1995.
Araneo et al., "Reversal of the Immunosenescent Phenotype by Dehydroepiandrosterone: Hormone Treatment Provides an Adjuvant Effect on the Immunization of Aged Mice with Recombinant Hepatitis B Surface Antigen," The Journal of Infectious Diseases, pp. 830-840, 1993.
Daynes et al., "Contrasting effects of glucocorticoids on the capacity of T cells to produce the growth factors interleukin 2 and interleukin 4," Eur. J. Immunol, pp. 2319-2325, 1989.
Daynes et al., "Induction of Common Mucosal Immunity by Hormonally Immunomodulated Peripheral Immunization," Infection and Immunity, vol. 64, No. 4, pp. 1100-1109, Apr. 1996.
Daynes et al., "Regulation of murine lymphokine production in vivo II. Dehydroepiandrosterone is a natural enhancer of interleukin 2 synthesis by helper T cells," Eur. J. Immunol, pp. 793-802, 1990.
Hennebold et al., "Regulation of Macrophage Dehydroepiandrosterone Sulfate Metabolism by Inflammatory Cytokines," Endocrinology, vol. 135, No. 1, pp. 67-75, 1994.
Phase II trials for Paradigm's DHEA (1992).
Suzuki et al., "Dehydroephiandrosterone Enhances IL2 Production and Cytotoxic Effector Function of Human T Cells," Clinical Immunology and Immunopathology, pp. 202-211, 1991.
Criares Theodore J.
Humanetics Corporation
Sherrill Michael S.
LandOfFree
UP-regulation of immune system with .DELTA. 5-Androstenes does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with UP-regulation of immune system with .DELTA. 5-Androstenes, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and UP-regulation of immune system with .DELTA. 5-Androstenes will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-149247